Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Interest Expenses (2023)

Historic Interest Expenses for Pasithea Therapeutics (KTTA) over the last 1 years, with Q2 2023 value amounting to -$117191.0.

  • Pasithea Therapeutics' Interest Expenses changed N/A to -$117191.0 in Q2 2023 from the same period last year, while for Mar 2024 it was -$117191.0, marking a year-over-year decrease of 193454.92%. This contributed to the annual value of $102.0 for FY2022, which is 7992.13% down from last year.
  • According to the latest figures from Q2 2023, Pasithea Therapeutics' Interest Expenses is -$117191.0.
  • Over the past 5 years, Pasithea Therapeutics' Interest Expenses peaked at $6388.0 during Q1 2023, and registered a low of -$117191.0 during Q2 2023.